07:00 , Mar 31, 2014 |  BioCentury  |  Finance

LSP's steady hand

When LSP-Life Sciences Partners launches a new healthcare venture fund next year it will stick to a strategy that has yielded 12 exits in the past 18 months - early stage, European drug development companies....
07:00 , Jun 17, 2013 |  BC Week In Review  |  Company News

Dezima management update

Dezima Pharma B.V. , Naarden, the Netherlands   Business: Cardiovascular   Hired: Rob de Ree as CEO, formerly CEO of Bmeye B.V. , which Edwards Lifesciences Corp. acquired; he replaces Interim CEO Sander van Deventer...